Literature DB >> 11514393

Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma.

R W Chiu1, L L Poon, T K Lau, T N Leung, E M Wong, Y M Lo.   

Abstract

BACKGROUND: Recently, apoptotic cells have been found in plasma obtained by centrifugation of blood from pregnant women, raising the question of what constitutes plasma and whether plasma is truly cell free. We compared the effects of different blood-processing protocols on the quantification, DNA composition, and day-to-day fluctuation of fetal and total DNA in maternal plasma.
METHODS: Blood samples were collected from healthy pregnant women. The blood sample from each individual was simultaneously processed by different means, including the following: Percoll separation, centrifugation, microcentrifugation, and filtration. The resulting plasma aliquots were subjected to real-time quantitative amplification of the beta-globin (for total DNA) and SRY (for fetal DNA) genes. The differences in the beta-globin and SRY DNA concentrations and the degree of variation between the various plasma aliquots were assessed statistically.
RESULTS: Different protocols of blood processing significantly affected the quantification and the day-to-day fluctuation of total (P <0.001), but not fetal (quantification, P = 0.336; fluctuation, P = 0.206), DNA in maternal plasma. The quantitative difference could be attributed to the fact that efficacies of different protocols for generating cell-free plasma vary. Processing blood samples by centrifugation followed by filtration or microcentrifugation is effective in producing cell-free plasma.
CONCLUSIONS: Standardization in plasma-processing protocols is needed for maternal plasma DNA analysis, especially for quantification of total DNA in maternal plasma. Such preanalytic factors may also affect other applications of plasma DNA analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514393

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  67 in total

1.  MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

Authors:  Chunming Ding; Rossa W K Chiu; Tze K Lau; Tse N Leung; Li C Chan; Amy Y Y Chan; Pimlak Charoenkwan; Ivy S L Ng; Hai-Yang Law; Edmond S K Ma; Xiangmin Xu; Chanane Wanapirak; Torpong Sanguansermsri; Can Liao; Mary Anne Tan Jin Ai; David H K Chui; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

2.  Detection of the placental epigenetic signature of the maspin gene in maternal plasma.

Authors:  Stephen S C Chim; Yu K Tong; Rossa W K Chiu; Tze K Lau; Tse N Leung; Lisa Y S Chan; Cees B M Oudejans; Chunming Ding; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.

Authors:  Alain R Thierry; Brice Pastor; Zhi-Qin Jiang; Anastasia D Katsiampoura; Christine Parseghian; Jonathan M Loree; Michael J Overman; Cynthia Sanchez; Safia El Messaoudi; Marc Ychou; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

Review 4.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

5.  Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.

Authors:  Ning Ren; Qing-Hai Ye; Lun-Xiu Qin; Bo-Heng Zhang; Yin-Kun Liu; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

6.  The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.

Authors:  Ning Ren; Lun-Xiu Qin; Hong Tu; Yin-Kun Liu; Bo-Heng Zhang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-25       Impact factor: 4.553

7.  Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing.

Authors:  Can Liao; Ai-hua Yin; Chun-fang Peng; Fang Fu; Jie-xia Yang; Ru Li; Yang-yi Chen; Dong-hong Luo; Yong-ling Zhang; Yan-mei Ou; Jian Li; Jing Wu; Ming-qin Mai; Rui Hou; Frances Wu; Hongrong Luo; Dong-zhi Li; Hai-liang Liu; Xiao-zhuang Zhang; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

Review 8.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

9.  Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.

Authors:  Tadeja Dovč-Drnovšek; Polona Klemenc; Nataša Toplak; Tanja Blejec; Irena Bricl; Primož Rožman
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

10.  Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood.

Authors:  Macy M S Heung; Shengnan Jin; Nancy B Y Tsui; Chunming Ding; Tak Y Leung; Tze K Lau; Rossa W K Chiu; Y M Dennis Lo
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.